To clarify whether the pharmacological benefits of sivelestat is dependent on lowering endotoxemia, we subcutaneously injected lipopolysaccharides (LPS) into sivelestat-treated ApoE-/- mice. This evidence concerns the gene APOE and serum lipopolysaccharide activity.